|
English
|
正體中文
|
简体中文
|
總筆數 :2856565
|
|
造訪人次 :
53382602
線上人數 :
1166
教育部委託研究計畫 計畫執行:國立臺灣大學圖書館
|
|
|
顯示項目 227951-227960 / 2348971 (共234898頁)
<< < 22791 22792 22793 22794 22795 22796 22797 22798 22799 22800 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2022-06-27T07:28:57Z |
Bisphosphonate Use Is Not Associated With Tuberculosis Risk Among Patients With Osteoporosis: A Nationwide Cohort Study
|
Chen, Jin-Hua; Lee, Chih-Hsin; Lee, Meng-Rui; Huang, Pei-Yu; Yen, Tzu-Hsin; Lee, Ming-Chia; Tsai, Ching-Wen; JANN-YUAN WANG; Lee, Jen-Ai |
| 國立臺灣海洋大學 |
2009-06 |
Bisphosphonate zoledronic acid enhances the inhibitory effects of gefitinib on EGFR-mutated non-small cell lung carcinoma cells
|
John Wen-Cheng Chang;Jia-Juan Hsieh;Yung-Chi Shen;Kun-Yun Yeh;Cheng-Hsu Wang;Ying-Ying Li;Todd Hsu |
| 國立臺灣海洋大學 |
2009 |
Bisphosphonate zoledronic acid enhances the inhibitory effects of gefitinib on EGFR-mutated non-small cell lung carcinoma cells
|
Chang JW;Hsieh JJ;Shen YC;Yeh KY;Wang CH;Li YY;Hsu T. |
| 中山醫學大學 |
2009 |
Bisphosphonate-related osteonecrosis of the jaw
|
Huang, Yu-Feng |
| 中山醫學大學 |
2009 |
bisphosphonate-related osteonecrosis of the jaw
|
Huang, Yu-Feng |
| 國立成功大學 |
2024-07~2024-08 |
Bisphosphonate-related osteonecrosis of the jaw: Is the medication duration related to advanced disease stage?
|
Su;Yu-Pin;Liu;Wen-Chung;Lin;Cheng-Ta;Chien;Hsin-;I;Yang;Kuo-Chung |
| 國立臺灣大學 |
2011 |
Bisphosphonates and Treatment of Osteonecrosis
|
陳彥宇; 楊榮森; CHEN, YAN-YU; YANG, RONG-SEN |
| 臺大學術典藏 |
2018-09-10T08:50:22Z |
Bisphosphonates and Treatment of Osteoporosis
|
Rong-Sen Yang; RONG-SEN YANG |
| 國立成功大學 |
2024 |
Bisphosphonates in the Prevention of Collapse of the Femoral Head in Nontraumatic Osteonecrosis
|
Chen;C, -H.;Lai;K, -A.;Lin;S, -Y.;Wang;G, -J. |
| 臺北醫學大學 |
2013 |
Bisphosphonates reduced the risk of acute myocardial infarction: a 2-year follow-up study
|
JH, Kang;JJ, Keller;HC, Lin |
顯示項目 227951-227960 / 2348971 (共234898頁)
<< < 22791 22792 22793 22794 22795 22796 22797 22798 22799 22800 > >>
每頁顯示[10|25|50]項目
|
